Immunoregulation—General

 Friday, May 6, 2022     2:00 PM – 4:00 PM ET     Room C123–124

Immunoregulation—General

Chairs

• Gudrun Debes, Thomas Jefferson Univ.
• Robert Lochhead, Med. Col. of Wisconsin

Speakers

• Neetu Gupta, Cleveland Clin., Myosin 18A is a novel checkpoint regulator in B cell differentiation and antibody-mediated immunity
• Shannon E. McGettigan, Thomas Jefferson Univ., Secreted IgM modulates the pool of IL-10producing B Cells
• Lance K. Blevins, Michigan State Univ., scRNA-Seq analysis of human CD5⁺ innate-like B cells identifies AHR expression as a marker of human CD9⁺ IL-10⁺ BRegulatory cells
• Jason M. Zimmerer, Wexner Med. Ctr., Ohio State Univ., Alloprimed antibody-suppressor CD8⁺ T cells preferentially kill alloprimed germinal center B cells
• Astrid E. Cardona, Univ. of Texas at San Antonio, Fibrinogen depletion ameliorates inflammation and vision loss in mouse models of diabetes
• Gautham S. Ramakrishnan, Univ. of Oklahoma Hlth. Sci. Ctr., SHIP-2 inhibits human microglia-like cell function in a TREM2 independent manner
• Dawit T.A. Mengistu, Univ. of Michigan, Tolerogenic markers on lung dendritic cells reversibly decrease following cigarette smoke exposure in mice
• Meihong Deng, Wexner Med. Ctr., Ohio State Univ., Activation of TLR9 signaling in fibroblastic reticular cells enhances anti-tumor immunity in peritoneal tumor via suppressing peritoneal resident macrophage retention